SOPHiA GENETICS SA Cash Flows From Used In Financing Activities
SOPHiA GENETICS SA (SOPH) reported Cash Flows From Used In Financing Activities of $30.18 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-03.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2026-03-03
| Period end | Cash Flows From Used In Financing Activities 6 month | Cash Flows From Used In Financing Activities 6 month as first filed | Cash Flows From Used In Financing Activities 12 month | Cash Flows From Used In Financing Activities 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | $30.18M 20-F · filed 2026-03-03 | |||
| 2025-06-30 | $32.55M 6-K · filed 2025-08-05 | |||
| 2024-12-31 | $9.86M 20-F · filed 2026-03-03 | $11.59M 20-F · filed 2025-03-04 | ||
| 2024-06-30 | $12.18M 6-K · filed 2025-08-05 | $12.75M 6-K · filed 2024-08-06 | ||
| 2023-12-31 | -$2.82M 20-F · filed 2026-03-03 | -$2.82M 20-F · filed 2024-03-05 | ||
| 2023-06-30 | -$1.55M 6-K · filed 2024-08-06 | |||
| 2022-12-31 | -$1.57M 20-F · filed 2025-03-04 | |||
| 2022-06-30 | -$179.00K 6-K · filed 2023-08-08 | |||
| 2021-12-31 | $237.77M 20-F · filed 2024-03-05 | |||
| 2020-12-31 | $107.05M 20-F · filed 2023-03-07 | |||
| 2019-12-31 | -$1.02M 20-F · filed 2022-03-15 |